Charles Schwab
HSTO

Charles Schwab’s Histogen Inc. Common Stock HSTO Stock Holding History

Charles Schwab’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-903
Closed -$1.06M – 3167
2018
Q1 		$1.06M Hold
903
– – ﹤0.01% 2499
2017
Q4 		$835K Hold
903
– – ﹤0.01% 2568
2017
Q3 		$992K Hold
903
– – ﹤0.01% 2511
2017
Q2 		$1.04M Buy
+903
New +$1.1M ﹤0.01% 2441
2014
Q2 		– Sell
-64
Closed -$104K – 3157
2014
Q1 		$104K Hold
64
– – ﹤0.01% 3038
2013
Q4 		$82K Hold
64
– – ﹤0.01% 3068
2013
Q3 		$130K Buy
+64
New +$119K ﹤0.01% 3015

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Charles Schwab's HSTO Position: Q2 2018 in Review

Charles Schwab sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 903 shares — an estimated $1.06M sold.

Charles Schwab first reported a position in HSTO in Q3 2013 and held it in 7 quarters. The position peaked at $1.06M in Q1 2018. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • Charles Schwab reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Charles Schwab sold 903 Histogen Inc. Common Stock shares in Q2 2018, an estimated $1.06M.
  • Charles Schwab first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 7 quarters.
  • Charles Schwab's Histogen Inc. Common Stock position peaked at $1.06M in Q1 2018.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on Charles Schwab's 13F filing for Q2 2018, filed 8 Aug 2018.